J Breast Cancer.  2012 Dec;15(4):373-380. 10.4048/jbc.2012.15.4.373.

Seroma Formation after Breast Cancer Surgery: What We Have Learned in the Last Two Decades

• Srivastava V
• Basu S
• Shukla VK

• KMID: 2286432
• DOI: http://doi.org/10.4048/jbc.2012.15.4.373

Abstract

Formation of a seroma most frequently occurs after mastectomy and axillary surgery. Prolonged drainage is troublesome as it increases the risk for infection and can significantly delay adjuvant therapy. Seroma has been defined as serous fluid collection under the skin flaps or in the axillary dead space following mastectomy and/or axillary dissection. Because the true etiology of a seroma is unknown, a multifactorial-causation hypothesis has been accepted. Surgical factors include technique, extent of dissection and the surgical devices used for dissection. Obliteration of dead space with various flap fixation techniques, use of sclerosants, fibrin glue and sealants, octreotide, and pressure garments have been attempted with conflicting results and none have been consistent. Early movement of the shoulder during the postoperative period may increase the formation of seroma, although delayed physiotherapy decreases the formation of seroma. A detailed analysis of the use of drains showed that use of single or multiple drains, early or late removal, and drains with or without suction are not significantly different for the incidence of seroma. Although there is evidence for reduced seroma formation after early drain removal, very early removal within 24 hours seems to increase formation of seroma. No patient or tumor factors seem to affect seroma formation except body mass index and body weight. Consensus is lacking among studies/trials with different groups producing conflicting evidence. Besides a few established factors such as body mass index, the use of electrocautery for dissection, early drain removal, low vacuum drains, obliteration of dead space, and delayed shoulder physiotherapy, most of the hypothesized causes have not been demonstrated consistently. Thus, seroma remains a threat to both the patient and surgeon. Recurrent transcutaneous aspiration remains the only successful management.

Keyword

Breast neoplasms; Lymph node excision; Mastectomy; Seroma

MeSH Terms

Body Mass Index
Body Weight
Breast
Breast Neoplasms
Consensus
Drainage
Electrocoagulation
Fibrin Tissue Adhesive
Humans
Incidence
Lymph Node Excision
Mastectomy
Octreotide
Postoperative Period
Sclerosing Solutions
Seroma
Shoulder
Skin
Suction
Vacuum
Fibrin Tissue Adhesive
Octreotide
Sclerosing Solutions

Reference

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008. 58:71–96.

2. Kumar S, Lal B, Misra MC. Post-mastectomy seroma: a new look into the aetiology of an old problem. J R Coll Surg Edinb. 1995. 40:292–294.

3. Stanczyk M, Grala B, Zwierowicz T, Maruszynski M. Surgical resection for persistent seroma, following modified radical mastectomy. World J Surg Oncol. 2007. 5:104.

4. Bryant M, Baum M. Postoperative seroma following mastectomy and axillary dissection. Br J Surg. 1987. 74:1187.

5. Willett WC, Rockhill B, Hankinson SE, Hunter DJ, Colditz GA. Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Epidemiology and nongenetic causes of breast cancer. Diseases of the Breast. 2000. 2nd ed. Philadelphia: Lippincott Williams & Wilkins;175–220.

6. Watt-Boolsen S, Nielsen VB, Jensen J, Bak S. Postmastectomy seroma. A study of the nature and origin of seroma after mastectomy. Dan Med Bull. 1989. 36:487–489.

7. Oertli D, Laffer U, Haberthuer F, Kreuter U, Harder F. Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer. Br J Surg. 1994. 81:856–859.

8. Bonnema J, van Geel AN, Wiggers T, Ligtenstein DA. Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer. Br J Surg. 1994. 81:1693.

9. Bonnema J, Ligtenstein DA, Wiggers T, van Geel AN. The composition of serous fluid after axillary dissection. Eur J Surg. 1999. 165:9–13.

10. Tejler G, Aspegren K. Complications and hospital stay after surgery for breast cancer: a prospective study of 385 patients. Br J Surg. 1985. 72:542–544.

11. Keogha GW, Doughty JC, McArdle CS, Cookea TG. Seroma formation related to electrocautery in breast surgery: a prospective randomized trial. Breast. 1998. 7:39–41.

12. Porter KA, O'Connor S, Rimm E, Lopez M. Electrocautery as a factor in seroma formation following mastectomy. Am J Surg. 1998. 176:8–11.

13. Kerin MJ, O'Hanlon DM, Kenny P, Kent PJ, Given HF. Argon-enhanced cutting and coagulation confers advantages over conventional electrocautery for mastectomy. Eur J Surg Oncol. 1996. 22:571–573.

14. Say CC, Donegan W. A biostatistical evaluation of complications from mastectomy. Surg Gynecol Obstet. 1974. 138:370–376.

15. Aitken DR, Hunsaker R, James AG. Prevention of seromas following mastectomy and axillary dissection. Surg Gynecol Obstet. 1984. 158:327–330.

16. Gonzalez EA, Saltzstein EC, Riedner CS, Nelson BK. Seroma formation following breast cancer surgery. Breast J. 2003. 9:385–388.

17. Dalberg K, Johansson H, Signomklao T, Rutqvist LE, Bergkvist L, Frisell J, et al. A randomised study of axillary drainage and pectoral fascia preservation after mastectomy for breast cancer. Eur J Surg Oncol. 2004. 30:602–609.

18. Woodworth PA, McBoyle MF, Helmer SD, Beamer RL. Seroma formation after breast cancer surgery: incidence and predicting factors. Am Surg. 2000. 66:444–450.

19. Somers RG, Jablon LK, Kaplan MJ, Sandler GL, Rosenblatt NK. The use of closed suction drainage after lumpectomy and axillary node dissection for breast cancer. A prospective randomized trial. Ann Surg. 1992. 215:146–149.

20. Browse DJ, Goble D, Jones PA. Axillary node clearance: who wants to immobilize the shoulder? Eur J Surg Oncol. 1996. 22:569–570.

21. Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP, et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol. 2005. 23:4312–4321.

22. Hashemi E, Kaviani A, Najafi M, Ebrahimi M, Hooshmand H, Montazeri A. Seroma formation after surgery for breast cancer. World J Surg Oncol. 2004. 2:44.

23. Wyman A, Rogers K. Randomized trial of laser scalpel for modified radical mastectomy. Br J Surg. 1993. 80:871–873.

24. Galatius H, Okholm M, Hoffmann J. Mastectomy using ultrasonic dissection: effect on seroma formation. Breast. 2003. 12:338–341.

25. Lumachi F, Brandes AA, Burelli P, Basso SM, Iacobone M, Ermani M. Seroma prevention following axillary dissection in patients with breast cancer by using ultrasound scissors: a prospective clinical study. Eur J Surg Oncol. 2004. 30:526–530.

26. Antonio M, Pietra T, Domenico L, Massimo D, Ignazio R, Antonio N, et al. Does LigaSure(TM) reduce fluid drainage in axillary dissection? A randomised prospective clinical trial. Ecancermedicalscience. 2007. 1:61.

27. Manouras A, Markogiannakis H, Genetzakis M, Filippakis GM, Lagoudianakis EE, Kafiri G, et al. Modified radical mastectomy with axillary dissection using the electrothermal bipolar vessel sealing system. Arch Surg. 2008. 143:575–580.

28. Magri K, Bertrand V, Sautière JL, Pivot X, Riethmuller D, Maillet R, et al. Cost effectiveness of Ligasure Precise versus surgical clips during axillary nodal dissection for breast cancer. J Gynecol Obstet Biol Reprod (Paris). 2006. 35:341–347.

29. Almond LM, Khodaverdi L, Kumar B, Coveney EC. Flap anchoring following primary breast cancer surgery facilitates early hospital discharge and reduces costs. Breast Care (Basel). 2010. 5:97–101.

30. Orr TG Jr. An incision and method of wound closure for radical mastectomy. Ann Surg. 1951. 133:565–566.

31. Keyes EL, Hawk BO, Sherwin CS. Basting the axillary flap for wounds of radical mastectomy. AMA Arch Surg. 1953. 66:446–451.

32. Larsen BB, Hugan C Jr. Fixation of skin flaps in radical mastectomy by subcutaneous sutures: observations. AMA Arch Surg. 1955. 71:419–423.

33. Schuijtvlot M, Sahu AK, Cawthorn SJ. A prospective audit of the use of a buttress suture to reduce seroma formation following axillary node dissection without drains. Breast. 2002. 11:94–96.

34. Hamy A, Bouchot-Hermouet FB, Bouchot O, Drianno JC, Guillard Y. Wadding of the axilla in the conservative treatment of cancer of the breast. Prevention of lymphocele. J Chir (Paris). 1990. 127:99–102.

35. O'Dwyer PJ, O'Higgins NJ, James AG. Effect of closing dead space on incidence of seroma after mastectomy. Surg Gynecol Obstet. 1991. 172:55–56.

36. Coveney EC, O'Dwyer PJ, Geraghty JG, O'Higgins NJ. Effect of closing dead space on seroma formation after mastectomy: a prospective randomized clinical trial. Eur J Surg Oncol. 1993. 19:143–146.

37. Gong Y, Xu J, Shao J, Cheng H, Wu X, Zhao D, et al. Prevention of seroma formation after mastectomy and axillary dissection by lymph vessel ligation and dead space closure: a randomized trial. Am J Surg. 2010. 200:352–356.

38. Chen CY, Hoe AL, Wong CY. The effect of a pressure garment on post-surgical drainage and seroma formation in breast cancer patients. Singapore Med J. 1998. 39:412–415.

39. O'Hea BJ, Ho MN, Petrek JA. External compression dressing versus standard dressing after axillary lymphadenectomy. Am J Surg. 1999. 177:450–453.

40. Eroglu E, Oral S, Unal E, Kalayci M, Oksüz O, Tilmaz M. Reducing seroma formation with fibrin glue in an animal mastectomy model. Eur J Surg Oncol. 1996. 22:137–139.

41. Wang JY, Goodman NC, Amiss LR Jr, Nguyen DH, Rodeheaver GT, Moore MM, et al. Seroma prevention in a rat mastectomy model: use of a light-activated fibrin sealant. Ann Plast Surg. 1996. 37:400–405.

42. Silverman RP, Elisseeff J, Passaretti D, Huang W, Randolph MA, Yaremchuk MJ. Transdermal photopolymerized adhesive for seroma prevention. Plast Reconstr Surg. 1999. 103:531–535.

43. Sanders RP, Goodman NC, Amiss LR Jr, Pierce RA, Moore MM, Marx G, et al. Effect of fibrinogen and thrombin concentrations on mastectomy seroma prevention. J Surg Res. 1996. 61:65–70.

44. Jain PK, Sowdi R, Anderson AD, MacFie J. Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. Br J Surg. 2004. 91:54–60.

45. Johnson L, Cusick TE, Helmer SD, Osland JS. Influence of fibrin glue on seroma formation after breast surgery. Am J Surg. 2005. 189:319–323.

46. Vaxman F, Kolbe A, Stricher F, Zund D, Volkmar P, Gros D, et al. Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. Eur Surg Res. 1995. 27:346–352.

47. Gioffrè Florio MA, Mezzasalma F, Manganaro T, Pakravanan H, Cogliandolo A. The use of fibrin glue in the surgery of breast carcinoma. G Chir. 1993. 14:239–241.

48. Moore MM, Nguyen DH, Spotnitz WD. Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. Am Surg. 1997. 63:97–102.

49. Gilly FN, François Y, Sayag-Beaujard AC, Glehen O, Brachet A, Vignal J. Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. Eur Surg Res. 1998. 30:439–443.

50. Mustonen PK, Härmä MA, Eskelinen MJ. The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scand J Surg. 2004. 93:209–212.

51. Chung TL, Holton LH 3rd, Goldberg NH, Silverman RP. Seroma prevention using Mytilus edulis protein in a rat mastectomy model. Breast J. 2006. 12:442–445.

52. Tekin E, Kocdor MA, Saydam S, Bora S, Harmancioglu O. Seroma prevention by using Corynebacterium parvum in a rat mastectomy model. Eur Surg Res. 2001. 33:245–248.

53. Saeb-Parsy K, Athanassoglou V, Benson JR. Talc seromadesis: a novel technique for the treatment of chronic seromas following breast surgery. Breast J. 2006. 12:502–504.

54. Gruver DI. Hypertonic saline for treatment of seroma. Plast Reconstr Surg. 2003. 112:934.

55. Widgerow AD, Song C, Ritz M, Potgieter E. Wound modulation via sclerotherapy and tissue adhesion. Observations and discussion. S Afr J Surg. 1997. 35:88–92.

56. Nichter LS, Morgan RF, Dufresne CR, Lambruschi P, Edgerton MT. Rapid management of persistent seromas by sclerotherapy. Ann Plast Surg. 1983. 11:233–236.

57. Sitzmann JV, Dufresne C, Zuidema GD. The use of sclerotherapy for treatment of postmastectomy wound seromas. Surgery. 1983. 93:345–347.

58. Rice DC, Morris SM, Sarr MG, Farnell MB, van Heerden JA, Grant CS, et al. Intraoperative topical tetracycline sclerotherapy following mastectomy: a prospective, randomized trial. J Surg Oncol. 2000. 73:224–227.

59. McCarthy PM, Martin JK Jr, Wells DC, Welch JS, Ilstrup DM. An aborted, prospective, randomized trial of sclerotherapy for prolonged drainage after mastectomy. Surg Gynecol Obstet. 1986. 162:418–420.

60. Carvalho P, Knight LL, Olson RD, Crowley JJ, Hawk PA, Charan NB. Effects of erythromycin on the rabbit pleura: its potential role as a pleural sclerosant. Am J Respir Crit Care Med. 1995. 151:1228–1232.

61. Ali-Khan AS, Orlando A, Kenealy J. Erythromycin sclerotherapy in the management of seroma. J Plast Reconstr Aesthet Surg. 2009. 62:e55–e58.

62. Ulíbarri JI, Sanz Y, Fuentes C, Mancha A, Aramendia M, Sánchez S. Reduction of lymphorrhagia from ruptured thoracic duct by somatostatin. Lancet. 1990. 336:258.

63. Carcoforo P, Soliani G, Maestroni U, Donini A, Inderbitzin D, Hui TT, et al. Octreotide in the treatment of lymphorrhea after axillary node dissection: a prospective randomized controlled trial. J Am Coll Surg. 2003. 196:365–369.

64. Nesvold IL, Dahl AA, Løkkevik E, Marit Mengshoel A, Fosså SD. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy. Acta Oncol. 2008. 47:835–842.

65. Shamley DR, Barker K, Simonite V, Beardshaw A. Delayed versus immediate exercises following surgery for breast cancer: a systematic review. Breast Cancer Res Treat. 2005. 90:263–271.

66. Dawson I, Stam L, Heslinga JM, Kalsbeek HL. Effect of shoulder immobilization on wound seroma and shoulder dysfunction following modified radical mastectomy: a randomized prospective clinical trial. Br J Surg. 1989. 76:311–312.

67. Petrek JA, Peters MM, Nori S, Knauer C, Kinne DW, Rogatko A. Axillary lymphadenectomy. A prospective, randomized trial of 13 factors influencing drainage, including early or delayed arm mobilization. Arch Surg. 1990. 125:378–382.

68. Lotze MT, Duncan MA, Gerber LH, Woltering EA, Rosenberg SA. Early versus delayed shoulder motion following axillary dissection: a randomized prospective study. Ann Surg. 1981. 193:288–295.

69. Schultz I, Barholm M, Gröndal S. Delayed shoulder exercises in reducing seroma frequency after modified radical mastectomy: a prospective randomized study. Ann Surg Oncol. 1997. 4:293–297.

70. Chen SC, Chen MF. Timing of shoulder exercise after modified radical mastectomy: a prospective study. Changgeng Yi Xue Za Zhi. 1999. 22:37–43.

71. Rodier JF, Gadonneix P, Dauplat J, Issert B, Giraud B. Influence of the timing of physiotherapy upon the lymphatic complications of axillary dissection for breast cancer. Int Surg. 1987. 72:166–169.

72. van der Horst CM, Kenter JA, de Jong MT, Keeman JN. Shoulder function following early mobilization of the shoulder after mastectomy and axillary dissection. Neth J Surg. 1985. 37:105–108.

73. Murphey DR Jr. The use of atmospheric pressure in obliterating axillary dead space following radical mastectomy. South Surg. 1947. 13:372–375.

74. Moss JP. Historical and current perspectives on surgical drainage. Surg Gynecol Obstet. 1981. 152:517–527.

75. Morris AM. A controlled trial of closed wound suction. Br J Surg. 1973. 60:357–359.

76. Divino CM, Kuerer HM, Tartter PI. Drains prevent seromas following lumpectomy with axillary dissection. Breast J. 2000. 6:31–33.

77. Bourke JB, Balfour TW, Hardcastle JD, Wilkins JL. A comparison between suction and corrugated drainage after simple mastectomy: a report of a controlled trial. Br J Surg. 1976. 63:67–69.

78. Thoren L. Z-plasty and suction drainage in radical mastectomy. Acta Chir Scand. 1964. 128:75–84.

79. Whitfield PC, Rainsbury RM. Suction versus siphon drainage after axillary surgery for breast cancer: a prospective randomized trial. Br J Surg. 1994. 81:547.

80. Petrek JA, Peters MM, Cirrincione C, Thaler HT. A prospective randomized trial of single versus multiple drains in the axilla after lymphadenectomy. Surg Gynecol Obstet. 1992. 175:405–409.

81. Terrell GS, Singer JA. Axillary versus combined axillary and pectoral drainage after modified radical mastectomy. Surg Gynecol Obstet. 1992. 175:437–440.

82. Britton BJ, Gilmore OJ, Lumley JS, Castleden WM. A comparison between disposable and non-disposable suction drainage units: a report of a controlled trial. Br J Surg. 1979. 66:279–280.

83. van Heurn LW, Brink PR. Prospective randomized trial of high versus low vacuum drainage after axillary lymphadenectomy. Br J Surg. 1995. 82:931–932.

84. Bonnema J, van Geel AN, Ligtenstein DA, Schmitz PI, Wiggers T. A prospective randomized trial of high versus low vacuum drainage after axillary dissection for breast cancer. Am J Surg. 1997. 173:76–79.

85. Burke CC, Zabka CL, McCarver KJ, Singletary SE. Patient satisfaction with 23-hour "short-stay" observation following breast cancer surgery. Oncol Nurs Forum. 1997. 24:645–651.

86. Holcombe C, West N, Mansel RE, Horgan K. The satisfaction and savings of early discharge with drain in situ following axillary lymphadenectomy in the treatment of breast cancer. Eur J Surg Oncol. 1995. 21:604–606.

87. Boman L, Björvell H, Cedermark B, Theve NO, Wilking N. Effects of early discharge from hospital after surgery for primary breast cancer. Eur J Surg. 1993. 159:67–73.

88. Goodman AA, Mendez AL. Definitive surgery for breast cancer performed on an outpatient basis. Arch Surg. 1993. 128:1149–1152.

89. Kambouris A. Physical, psychological, and economic advantages of accelerated discharge after surgical treatment for breast cancer. Am Surg. 1996. 62:123–127.

90. Tan LR, Guenther JM. Outpatient definitive breast cancer surgery. Am Surg. 1997. 63:865–867.

91. Orr RK, Ketcham AS, Robinson DS, Moffat FL, Tennant ND. Early discharge after mastectomy. A safe way of diminishing hospital costs. Am Surg. 1987. 53:161–163.

92. Edwards MJ, Broadwater JR, Bell JL, Ames FC, Balch CM. Economic impact of reducing hospitalization for mastectomy patients. Ann Surg. 1988. 208:330–336.

93. Bonnema J, van Wersch AM, van Geel AN, Pruyn JF, Schmitz PI, Paul MA, et al. Medical and psychosocial effects of early discharge after surgery for breast cancer: randomised trial. BMJ. 1998. 316:1267–1271.

94. Clark JA, Kent RB 3rd. One-day hospitalization following modified radical mastectomy. Am Surg. 1992. 58:239–242.

95. Hoehn JL. Definitive breast cancer surgery as an outpatient: a rational basis for the transition. Semin Surg Oncol. 1996. 12:53–58.

96. Tadych K, Donegan WL. Postmastectomy seromas and wound drainage. Surg Gynecol Obstet. 1987. 165:483–487.

97. Barwell J, Campbell L, Watkins RM, Teasdale C. How long should suction drains stay in after breast surgery with axillary dissection? Ann R Coll Surg Engl. 1997. 79:435–437.

98. Kopelman D, Klemm O, Bahous H, Klein R, Krausz M, Hashmonai M. Postoperative suction drainage of the axilla: for how long? Prospective randomised trial. Eur J Surg. 1999. 165:117–120.

99. Parikh HK, Badwe RA, Ash CM, Hamed H, Freitas R Jr, Chaudary MA, et al. Early drain removal following modified radical mastectomy: a randomized trial. J Surg Oncol. 1992. 51:266–269.

100. Inwang R, Hamed H, Chaudary MA, Fentiman IS. A controlled trial of short-term versus standard axillary drainage after axillary clearance and iridium implant treatment of early breast cancer. Ann R Coll Surg Engl. 1991. 73:326–328.

101. Yii M, Murphy C, Orr N. Early removal of drains and discharge of breast cancer surgery patients: a controlled prospective clinical trial. Ann R Coll Surg Engl. 1995. 77:377–379.

102. Liu CD, McFadden DW. Overnight closed suction drainage after axillary lymphadenectomy for breast cancer. Am Surg. 1997. 63:868–870.

103. Cameron AE, Ebbs SR, Wylie F, Baum M. Suction drainage of the axilla: a prospective randomized trial. Br J Surg. 1988. 75:1211.

104. Jeffrey SS, Goodson WH 3rd, Ikeda DM, Birdwell RL, Bogetz MS. Axillary lymphadenectomy for breast cancer without axillary drainage. Arch Surg. 1995. 130:909–912.

105. Siegel BM, Mayzel KA, Love SM. Level I and II axillary dissection in the treatment of early-stage breast cancer. An analysis of 259 consecutive patients. Arch Surg. 1990. 125:1144–1147.

106. Zavotsky J, Jones RC, Brennan MB, Giuliano AE. Evaluation of axillary lymphadenectomy without axillary drainage for patients undergoing breast-conserving therapy. Ann Surg Oncol. 1998. 5:227–231.

107. Kuroi K, Shimozuma K, Taguchi T, Imai H, Yamashiro H, Ohsumi S, et al. Evidence-based risk factors for seroma formation in breast surgery. Jpn J Clin Oncol. 2006. 36:197–206.

108. Segura-Castillo JL, Estrada-Rivera O, Castro-Cervantes JM, Cortés-Flores AO, Velázquez-Ramírez GA, González-Ojeda A. Reduction of lymphatic drainage posterior to modified radical mastectomy with the application of fibrin glue. Cir Cir. 2005. 73:345–350.

109. Chilson TR, Chan FD, Lonser RR, Wu TM, Aitken DR. Seroma prevention after modified radical mastectomy. Am Surg. 1992. 58:750–754.